Target intelligence / Profile preview

Neurogenic differentiation factor 2 (NEUROD2)

Target
NEUROD2
Molecular classification
Transcription factor, Basic helix-loop-helix (bHLH) protein
01

Overview

Neurogenic differentiation factor 2 (NEUROD2) is a basic helix-loop-helix (bHLH) transcription factor critically involved in the determination and maintenance of neuronal identity during development[1][6]. NEUROD2 mediates transcriptional activation from neuron-specific promoters and regulates gene networks essential for neuronal fate specification, cortical neuron migration, dendrite and synapse development, and synaptic plasticity[4][8]. It acts as a repressor of neuronal differentiation by inducing downstream targets such as ZEB1 and controlling the repression of REST expression[6]. NEUROD2 is essential for post-migratory neuronal maturation, the establishment of proper synaptic connections, and the development of several key brain regions, including the hippocampus, cortex, amygdala, and hypothalamic-pituitary axis[6][8]. Pathogenic variants of NEUROD2 are associated with early-onset epilepsy and neurodevelopmental syndromes characterized by migration defects, abnormal spine density, and impaired neuronal function[4][6]. There are currently no clinically approved drugs known to directly target NEUROD2.

Other names
NeuroD2NDRFbHLHa1NeuroD-related factorClass A basic helix-loop-helix protein 1neurogenic differentiation 2
02

Biological functions

Neuronal differentiation and fate determinationRegulation of transcriptionSynaptic plasticity and maturationControl of dendritic spine turnover and synapse densityRegulation of calcium signalingPrevention of GABAergic differentiation in specific neuronal progenitors
03

Disease associations

Neurodevelopmental disorders (including Developmental and Epileptic Encephalopathy 72 and Early Infantile Developmental and Epileptic Encephalopathy)Potential role in brain connectivity/migration disorders
04

Safety considerations

Loss-of-function mutations can cause severe neurodevelopmental phenotypes, including epilepsy and intellectual disabilityMutations may affect cortical neuron migration and synaptic development

Beyond the preview

Go deeper on Neurogenic differentiation factor 2 (NEUROD2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurogenic differentiation factor 2 (NEUROD2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call